Display options
Share it on

J Neurooncol. 2021 May;153(1):89-98. doi: 10.1007/s11060-021-03747-1. Epub 2021 Apr 06.

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints.

Journal of neuro-oncology

Pim B van der Meer, Johan A F Koekkoek, Martin J van den Bent, Linda Dirven, Martin J B Taphoorn

Affiliations

  1. Department of Neurology, Leiden University Medical Center, PO BOX 9600, Leiden, 2300 RC, The Netherlands. [email protected].
  2. Department of Neurology, Leiden University Medical Center, PO BOX 9600, Leiden, 2300 RC, The Netherlands.
  3. Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
  4. Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.

PMID: 33822293 PMCID: PMC8131297 DOI: 10.1007/s11060-021-03747-1

Abstract

INTRODUCTION: AEDs have been associated with depression, anxiety, and cognitive impairment, all frequent complications of glioma and its subsequent treatment, with considerable morbidity and an adverse effect on health-related quality of life. This study aimed to determine the independent association between AED use and self-reported depression, anxiety, and subjective cognitive impairment in glioma patients.

METHODS: In this multicenter cross-sectional study, depression and anxiety were assessed with the HADS and subjective cognitive impairment was assessed with the MOS-CFS. Univariable logistic regression analyses were performed on all potential confounding predictor variables. Potential confounders were included in the multivariable analyses if p-value < 0.1, to evaluate whether use of AEDs was independently related to depression, anxiety, and/or subjective cognitive impairment.

RESULTS: A total of 272 patients were included. Prevalence of depression differed significantly between patients not using (10%) and using AEDs (21%, unadjusted Odds Ratio [uOR] = 2.29 [95%CI 1.05-4.97], p = 0.037), but after correction for confounders the statistical significant difference was no longer apparent (adjusted Odds Ratio [aOR] = 1.94 [95%CI 0.83-4.50], p = 0.125). Prevalences of anxiety (aOR = 1.17 [95%CI 0.59-2.29], p = 0.659) and subjective cognitive impairment (aOR = 0.83 [95%CI 0.34-2.04], p = 0.684) did not differ significantly before or after adjustment of confounders between patients not using (19% and 16%, respectively) and using AEDs (26% and 21%, respectively).

CONCLUSIONS: Our results indicate AED use was not independently associated with concurrent depression, anxiety, or subjective cognitive impairment in glioma patients. Alternative factors seem to have a greater contribution to the risk of developing neuropsychiatric symptoms in glioma patients.

Keywords: Anticonvulsants; Anxiety; Cognition; Depression; Glioma; Seizures

References

  1. Oncologist. 2014 Jul;19(7):751-9 - PubMed
  2. Neuro Oncol. 2012 Sep;14 Suppl 4:iv17-24 - PubMed
  3. J Neurooncol. 2018 Dec;140(3):739-748 - PubMed
  4. Neurology. 2000 May 23;54(10):1886-93 - PubMed
  5. Clin Pharmacol Ther. 1997 Dec;62(6):592-5 - PubMed
  6. J Neurol. 2018 Jun;265(6):1432-1442 - PubMed
  7. PLoS One. 2017 Jul 17;12(7):e0180470 - PubMed
  8. Acta Psychiatr Scand. 1983 Jun;67(6):361-70 - PubMed
  9. Seizure. 2007 Jun;16(4):296-304 - PubMed
  10. Epilepsy Behav. 2004 Feb;5 Suppl 1:S66-76 - PubMed
  11. BMC Med Res Methodol. 2008 Oct 30;8:70 - PubMed
  12. Epilepsia. 2013 Dec;54 Suppl 9:97-104 - PubMed
  13. Epilepsy Res. 2001 Apr;44(1):53-63 - PubMed
  14. Neuro Oncol. 2013 Feb;15(2):216-23 - PubMed
  15. J Pain Symptom Manage. 1995 Feb;10(2):131-41 - PubMed
  16. Lancet Neurol. 2009 Sep;8(9):810-8 - PubMed
  17. J Clin Oncol. 2001 Oct 15;19(20):4037-47 - PubMed
  18. Lancet Neurol. 2007 May;6(5):421-30 - PubMed
  19. Am J Epidemiol. 2007 Mar 15;165(6):710-8 - PubMed
  20. Eur J Neurol. 2017 Oct;24(10):1283-1289 - PubMed
  21. Psychol Med. 1997 Mar;27(2):363-70 - PubMed
  22. JAMA Neurol. 2019 Apr 1;76(4):440-446 - PubMed
  23. Ann Neurol. 2003 Oct;54(4):514-20 - PubMed
  24. Drugs. 2002;62(4):593-604 - PubMed
  25. Lancet. 2002 Nov 2;360(9343):1361-8 - PubMed
  26. Epilepsy Behav. 2017 Nov;76:24-31 - PubMed
  27. J Natl Cancer Inst. 2011 Jan 5;103(1):61-76 - PubMed
  28. Epilepsy Behav. 2008 Nov;13(4):642-9 - PubMed
  29. Eur J Cancer. 1998 Jan;34(1):98-102 - PubMed
  30. Nat Clin Pract Neurol. 2006 Sep;2(9):494-503; quiz 1 p following 516 - PubMed
  31. J Neurol Neurosurg Psychiatry. 2014 Feb;85(2):230-5 - PubMed
  32. Neurooncol Pract. 2015 Mar;2(1):20-31 - PubMed
  33. J Nurs Scholarsh. 2007;39(1):61-7 - PubMed
  34. Neuro Oncol. 2016 Jun;18(6):779-89 - PubMed
  35. Am J Phys Med Rehabil. 2001 May;80(5):346-50 - PubMed
  36. J Clin Oncol. 2011 Nov 10;29(32):4307-12 - PubMed
  37. Neuro Oncol. 2012 Apr;14(4):392-404 - PubMed
  38. J Neurol. 2017 May;264(5):921-927 - PubMed
  39. Lancet Neurol. 2004 Mar;3(3):159-68 - PubMed
  40. Acta Neuropathol. 2016 Jun;131(6):803-20 - PubMed
  41. J Infus Nurs. 2004 Jul-Aug;27(4):263-9 - PubMed

Publication Types